Literature DB >> 18265377

The detection of MAPK signaling.

Yoav Shaul1, Rony Seger.   

Abstract

Mitogen-activated protein kinase (MAPK) cascades are central pathways that participate in the intracellular transmission of extracellular signals. Each of the MAPK signaling cascades seems to consist of three to five tiers of protein kinases that sequentially activate each other by phosphorylation. Since the majority of MAPK cascade components are kinases, the methods used to detect their activation involve determining phosphorylation state and protein kinase activities. The primary method describes the use of immunoblotting with specific anti-phospho antibody to detect activation of MAPK components. Alternative methods described are immunoprecipitation of desired protein kinases followed by phosphorylation of specific substrates and the use of an in-gel kinase assay. These methods have proven useful in the study of the MAPK signaling cascades.

Mesh:

Substances:

Year:  2006        PMID: 18265377     DOI: 10.1002/0471142727.mb1812s73

Source DB:  PubMed          Journal:  Curr Protoc Mol Biol        ISSN: 1934-3647


  3 in total

1.  Analysis of Progranulin-Mediated Akt and MAPK Activation.

Authors:  Shi-Qiong Xu; Simone Buraschi; Ryuta Tanimoto; Manuela Stefanello; Antonino Belfiore; Renato V Iozzo; Andrea Morrione
Journal:  Methods Mol Biol       Date:  2018

2.  Novel Reporter for Faithful Monitoring of ERK2 Dynamics in Living Cells and Model Organisms.

Authors:  François Sipieter; Benjamin Cappe; Mariano Gonzalez Pisfil; Corentin Spriet; Jean-François Bodart; Katia Cailliau-Maggio; Peter Vandenabeele; Laurent Héliot; Franck B Riquet
Journal:  PLoS One       Date:  2015-10-30       Impact factor: 3.240

3.  Intranasal administration of a stapled relaxin-3 mimetic has anxiolytic- and antidepressant-like activity in rats.

Authors:  Subhi Marwari; Anders Poulsen; Norrapat Shih; Rajamani Lakshminarayanan; R Manjunatha Kini; Charles William Johannes; Brian William Dymock; Gavin Stewart Dawe
Journal:  Br J Pharmacol       Date:  2019-09-11       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.